ARCHIVES

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

Court Upholds FDA Position On Definition Of A Drug.

February 23, 2001

Budge Act Includes Language On Coverage Of Oral Cancer Drugs

August 13, 1993

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

August 29, 2008

NIH Breaks Ground For Clinical Center

November 14, 1997

NCI Advisors Ok Study of Cancer In Farmers; Commit $6.6 Million to Five Year Contracts

April 3, 1992

OMB Restriction On Reprogramming Threatens Grants Of Three Centers, Possible Restorations

June 6, 1986